The Synthetic Biologics, Inc. (NYSE:SYN) Stock Is Positioned For Success

The SYN stock price fluctuated between $0.4884 and $0.5143 throughout the trading session with the volume trading being 1M shares, which represented a negative variation when compared to the three months average volume of 3M shares.

The share price of Synthetic Biologics, Inc. (NYSE American:SYN) dipped -1.09% to close Tuesday’s market session at $0.5066, lower as compared to yesterday’s close which brings the market valuation of the company to $66.89M.

The 52-week high for the Synthetic Biologics, Inc.’s shares is $1.7000. That puts it -70.20% from that peak but still a -3.77% gain since the share price dropped to a 52-week low of $0.2600, while the S&P 500’s share price change was of 37.41%.

What does the trading volume tell us about the SYN stock?

During the last trading session, Synthetic Biologics, Inc. (NYSE American:SYN) has seen decay in its daily volume. The daily volume was of 3M, while in the last 10 days the average was 1.63M and last three months – 2.76M.
The decreasing interest in the SYN stock from the investors is helping to drive the stock price down.

Growing short interest

The Synthetic Biologics, Inc.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 359.26k shares being shorted which translates into 0.1 of a short ratio for SYN, while in the previous month the shorted shares were 782.33k.

Synthetic Biologics, Inc. (NYSE:SYN) financials

With a market cap of 66.89M, Synthetic Biologics, Inc. holds a total cash of $76.89M that translates into $0.29 per share, while the total debt is of $405k.